Expression of the NF-κB-responsive gene BTG2 is aberrantly regulated in breast cancer

[1]  S. Maheswaran,et al.  Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells , 2003, Molecular and Cellular Endocrinology.

[2]  Richard Simon,et al.  Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Melamed,et al.  Expression of B-cell translocation gene 2 protein in normal human tissues. , 2002, Tissue & cell.

[4]  T. Soussi,et al.  The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. , 2002, Gene.

[5]  P. Donahoe,et al.  Mullerian-inhibiting substance regulates NF–κB signaling in the prostate in vitro and in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Rubin,et al.  Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. , 2001, Carcinogenesis.

[7]  P. Donahoe,et al.  Müllerian Inhibiting Substance Regulates NFκB Signaling and Growth of Mammary Epithelial Cells in Vivo* , 2001, The Journal of Biological Chemistry.

[8]  P. Donahoe,et al.  Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway* , 2000, The Journal of Biological Chemistry.

[9]  Cheryl Jorcyk,et al.  The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma , 2000, Oncogene.

[10]  P. Hainaut,et al.  BTG gene expression in the p53‐dependent and ‐independent cellular response to DNA damage , 2000, Molecular carcinogenesis.

[11]  Christian Kaltschmidt,et al.  Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators , 1999, Oncogene.

[12]  W. Huttner,et al.  Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Park,et al.  Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin‐dependent kinase 4 proteins due to overexpression of TIS21 , 1998, Molecular carcinogenesis.

[14]  J. Magaud,et al.  Interaction of BTG1 and p53-regulatedBTG2 Gene Products with mCaf1, the Murine Homolog of a Component of the Yeast CCR4 Transcriptional Regulatory Complex* , 1998, The Journal of Biological Chemistry.

[15]  T. Park,et al.  Enzymatic methylation of recombinant TIS21 protein‐arginine residues , 1998, Biochemistry and molecular biology international.

[16]  D. Baltimore,et al.  Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. , 1997, Immunity.

[17]  S. Clarke,et al.  The Mammalian Immediate-early TIS21 Protein and the Leukemia-associated BTG1 Protein Interact with a Protein-arginine N-Methyltransferase* , 1996, The Journal of Biological Chemistry.

[18]  N. Colburn,et al.  Preferential primary‐response gene expression in promotion‐resistant versus promotion‐sensitive JB6 cells , 1994, Molecular carcinogenesis.

[19]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[20]  S. van den Heuvel,et al.  Distinct roles for cyclin-dependent kinases in cell cycle control. , 1993, Science.

[21]  P. Donahoe,et al.  Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects. , 1992, Protein expression and purification.

[22]  E. Shooter,et al.  Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[24]  L. Chen,et al.  Loss of heterozygosity on chromosome 1q in human breast cancer. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  N. Kim,et al.  Experimental Oncology Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines , 2005, Journal of Cancer Research and Clinical Oncology.